EverImmune
Villejuif · Founded 2016
About EverImmune
EverImmune focuses on the development of promising projects in the field of microbiome oncology. It is devoted to treating cancer patients. EverImmune provides a series of live biotherapeutic products (LBP), used as oral adjuvants to anticancer immunotherapies. EverImmune plans to test Oncobax® in well-designed clinical trials.
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.4M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Sep 2023)
- Website: https://www.everimmune.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/everimmune-36116 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.